Interestingly, the inhibition of the activin receptor-like kinase (ALK)-2 improves anemia in mouse models of iron-refractory/iron-deficiency anemia by repressing hepcidin, a critical mediator of anemia of chronic disease [36,37]. Here, ACVR1 is linked to anemia (phenotype).